0001127602-16-041961.txt : 20160217 0001127602-16-041961.hdr.sgml : 20160217 20160217180321 ACCESSION NUMBER: 0001127602-16-041961 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160212 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCANGOS GEORGE A CENTRAL INDEX KEY: 0001202102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 161435371 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-02-12 0000875045 BIOGEN INC. BIIB 0001202102 SCANGOS GEORGE A BIOGEN INC. 225 BINNEY STREET CAMBRIDGE MA 02142 1 1 Chief Executive Officer Common Stock 2016-02-12 4 M 0 4512 0 A 51571 D Common Stock 2016-02-12 4 F 0 2132 247.22 D 49439 D Common Stock 2016-02-12 4 M 0 9189 0 A 58628 D Common Stock 2016-02-12 4 F 0 4324 247.22 D 54304 D Common Stock 2016-02-12 4 A 0 11390 0 A 65694 D Common Stock 2016-02-12 4 F 0 5359 247.22 D 60335 D Common Stock 5378 I by Trust Common Stock 5378 I by Trust Restricted Stock Unit 0 2016-02-12 4 M 0 4512 0 D 2017-02-12 Common Stock 4512 16484 D Restricted Stock Unit 0 2016-02-12 4 M 0 9189 0 D 2017-02-12 Common Stock 9189 9182 D Restricted Stock Unit 0 2016-02-12 4 J 0 5982 0 D 2017-02-12 Common Stock 5982 10502 D The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]). This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. /s/ Matthew S. Gilman, Attorney in Fact for George A. Scangos 2016-02-17